Eli Lilly and Company (LLY) and Boehringer Mannheim Corporation Present Health Outcomes Data for Investigational Novel Basal Insulin Analogue
10/2/2012 10:36:37 AM
More...
|
Boehringer Mannheim Corporation, Pfizer Inc. (PFE)'s Drug Helped to Delay Asthma Attacks
8/31/2012 9:29:06 AM
More...
|
Boehringer Mannheim Corporation Completes Patient Entry for Phase III Trial Program in Hepatitis C
12/9/2011 7:09:58 AM
More...
|
Boehringer Mannheim Corporation Enrolls First Patient in Phase III Program for New Once-Daily Fixed-Dose Combination of Tiotropium Plus Olodaterol in COPD
9/21/2011 9:40:55 AM
More...
|
Plasmid DNA Manufacturing Technology: Development Of Boehringer Ingelheim GmbH With BIA Separations
10/19/2005 5:13:05 PM
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Submits New Drug Application To U.S. FDA For Tipranavir
10/19/2005 5:11:54 PM
More...
|